Hepcdac Tablet (Daclatasvir)

In stock
90% of 100

Buy Hepcdac 60 mg (Daclatasvir), Hepcdac (Daclatasvir) is an antiviral medicine that prevents the hepatitis C virus (HCV) from multiplying in your body. Hepcdac is used to treat genotype 1 and genotype 3 chronic hepatitis C in adults with or without cirrhosis. Hepcdacis was given together with another drug called Sovaldi (sofosbuvir). Hepcdac tablets contain the active ingredient daclatasvir, which is a type of medicine called an antiviral. Daklinza is another brand name for Daclatasvir.

Read More

Hepcdac 60mg Tablet (Daclatasvir 60mg)

PackageQTYPriceAdd To Cart
28 Tablet/s (1 Bottle) $186.43
56 Tablet/s (2 Bottles) $373.00
84 Tablet/s (3 Bottles) $560.00

What is Hepcdac Tablet (Daclatasvir)?

Hepcdac (Daclatasvir) is an antiviral medicine that prevents the hepatitis C virus (HCV) from multiplying in your body. Hepcdac is used to treat genotype 1 and genotype 3 chronic hepatitis C in adults with or without cirrhosis. Hepcdacis was given together with another drug called Sovaldi (sofosbuvir). Hepcdac tablets contain the active ingredient daclatasvir, which is a type of medicine called an antiviral. It is used in combination with other medicines to treat chronic hepatitis C. Hepatitis C is a virus that infects the liver and leads to liver damage. Once the virus is inside the liver cells it multiplies. Part of this process involves the virus making copies of its genetic material (RNA and DNA).

Daclatasvir price: You can find the price of daclatasvir, marketed as Daklinza, on our website. We offer competitive pricing for this medication to ensure accessibility and affordability for our customers.

Daclatasvir generic: Daclatasvir is available as a generic medication, which means it is produced and sold under its chemical name rather than a brand name. Generic versions of daclatasvir are often more cost-effective while maintaining the same quality and efficacy.

Daclatasvir brand name: The brand name for the medication containing daclatasvir is Daklinza. It is a well-known and trusted brand used for the treatment of hepatitis C virus (HCV) infection.

Daclatasvir for hepatitis C: Daclatasvir, commonly prescribed as Daklinza, is highly effective in treating hepatitis C virus (HCV) infection. It is often used in combination with other antiviral medications to achieve a sustained virologic response and improve overall liver health.

How does Hepcdac Tablet (Daclatasvir) work?

Daclatasvir works by blocking the action of an enzyme called 5A (NS5A) in the hepatitis C virus, which is essential for the virus to multiply. This stops the hepatitis C virus from multiplying, which lowers the amount of the hepatitis C virus in the liver. This helps to reduce liver damage and improves liver function. Daclatasvir must be used in combination with other medicines that attack the hepatitis C virus in different ways. If daclatasvir is used on its own there is a high chance that the hepatitis C virus will become resistant to it.

What is Hepcdac Tablet (Daclatasvir) used for?

Treating chronic hepatitis C infections (genotypes 1, 3, and 4) in adults with uncomplicated liver disease whose liver is still functioning correctly (compensated liver disease). Hepcdac may be used in people who have not yet received treatment for their hepatitis C, or for people whose disease has not improved with previous treatment. Hepcdac may be used in combination with sofosbuvir (Sovaldi), either with or without ribavirin (Rebetol), or with ribavirin plus peginterferon alfa (ViraferonPeg or Pegasys).

Hepcdac Tablet (Daclatasvir) side effects

Get emergency medical help if you have signs of an allergic reaction to Hepcdac: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Before taking Hepcdac Tablet (Daclatasvir) precautions to be taken

  • You should not use Hepcdac if you are allergic to daclatasvir. If you take daclatasvir with sofosbuvir, there may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.
  • Some medicines can interact with Hepcdac and should not be used at the same time. Your doctor may need to change your treatment plan if you use any of the following drugs: rifampin, carbamazepine, and phenytoin.
  • To make sure Hepcdac is safe for you, tell your doctor if you have:
  • liver problems other than hepatitis C;
  • heart disease;
  • if you also use amiodarone (a heart rhythm medicine); or
  • if you have received a liver transplant.
  • It is not known whether Hepcdac will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
  • It is not known whether daclatasvir passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breastfeeding a baby.
  • Hepcdac is not approved for use by anyone younger than 18 years old.

How should I take Hepcdac?

  • Hepcdac is usually taken for 12 weeks. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
  • Hepcdac must be given in combination with sofosbuvir and it should not be used alone.
  • You may take Hepcdac with or without food.
  • Hepatitis C is often treated with a combination of drugs. Use all medications as directed by your doctor. Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.
  • Do not stop using any of your hepatitis C medicines without your doctor's advice. Do not change your doses or medication schedule without first asking your doctor. Every person with chronic hepatitis C should remain under the care of a doctor.
  • You will need frequent blood tests to check your liver function while using Hepcdac.
  • Store at room temperature away from moisture and heat.
  • Hepcdac Tablet (Daclatasvir) dosing information
  • Usual Adult Dose for Chronic Hepatitis C:
  • 60 mg orally once a day for 12 weeks

-Sustained virologic response rates reduced in HCV genotype 3-infected patients with cirrhosis using this drug with sofosbuvir for 12 weeks; optimal duration of therapy has not been established for patients with cirrhosis.
-The manufacturer product information for sofosbuvir should be consulted.

Use: In combination with sofosbuvir, for the treatment of patients with chronic HCV genotype 3 infection

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up for the missed dose.

What happens if I overdose?

Seek emergency medical attention or call to your doctor.

What should I avoid while taking Hepcdac?

Taking Hepcdac will not prevent you from passing hepatitis C to other people. Do not have unprotected sex or share razors or toothbrushes. Talk with your doctor about safe ways to prevent HCV transmission during sex. Sharing drugs or medicine needles is never safe, even for a healthy person.

Drug Interaction with Hepcdac Tablet (Daclatasvir)

Daclatasvir Tablet may interact with other medications, including prescription drugs, over-the-counter medications, and herbal supplements. These interactions can affect the metabolism, efficacy, and safety of both Daclatasvir and the co-administered medications. It is crucial to inform your healthcare provider about all the medications you are taking to avoid any potential interactions. One notable drug interaction is with strong cytochrome P450 (CYP) 3A inhibitors, such as certain antiviral drugs, antifungals, and antibiotics. Co-administration of Daclatasvir Tablet with strong CYP3A inhibitors may increase the exposure to Daclatasvir, leading to a higher risk of side effects. Dose adjustments or alternative medications may be required in such cases. On the other hand, Daclatasvir Tablet is a mild inducer of P-glycoprotein (P-gp) and may reduce the efficacy of medications that are substrates of P-gp. It is essential to consult with your healthcare provider if you are taking any medications that are influenced by P-gp to ensure appropriate dosing and maintain therapeutic efficacy.


What is the Generic Name for the trade name drug "Daklinza"?

Daclatasvir mepesuccinate is the Generic Name for the trade name drug Hepcdac.

What is the Manufacturer's Name of Hepcdac?

Hepcdac is manufactured by Mylan Pharma, India

Is Hepcdac approved by FDA?

Yes, Hepcdac is approved by FDA.

What dosage and form of Hepcdac is available?

Hepcdac is available in 30 mg & 60 mg film-coated tablets

What are the indications and usage of Hepcdac?

Hepcdac is an anti-body-drug conjugate indicated for: The treatment of The treat adults with hepatitis C. after the failure of autologous stem cell transplant (ASCT) or after the failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates and The treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen

These indications are based on the response rate. There are no data available demonstrating improvement in patient-reported outcomes or survival with Hepcdac.


SafeGenericPharmacy is able to source Hepcdac Brentuximab Vedotin (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.


SafeGenericPharmacy is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patients address only from India.

Is Hepcdac available in India?

Hepcdac is a pharmaceutical drug that legally requires a medical prescription to be dispensed.

onlinegenericmedicine.com facilitates the Export of cancer medicines on the named patient supply. SafeGenericPharmacy is a facilitator providing input

On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune, etc.)

Medicine Price

  • Finding Genuine and reliable sources from Europe, the USA, and Australia
  • Ensuring 100% transparency.
  • Hepcdac can be made available in Europe, the USA, and Australia, SafeGenericPharmacy can facilitate the supply of Hepcdac (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
  • Please email us for a bulk discount, We take guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

How order will be confirmed?

The order will be confirmed only after the receipt of

Valid prescription of Oncologist

Import permit if applicable

Where can I Buy Hepcdac (Daclatasvir Tablets)?

  • onlinegenericmedicine.com connects buyers with suppliers who can ship Hepcdac (Daclatasvir Tablets) (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Hepcdac is manufactured by Mylan Pharma Ltd.
  • onlinegenericmedicine.com provides options for choosing exporters and suppliers of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
  • Hepcdac price online
  • this can be the opportunity to get the best prices for your hep c treatment.
  • Before contacting us please take into account that the medicine has to be prescribed by a doctor, and you must provide the prescription to us and we will verify it with your doctor.
  • We are able to deliver Hepcdac to almost every country in the world, directly to your doctor’s office or through a net of allied pharmacies.
  • If you want more information about Hepcdac, to get more information about the HCV visit our Hep C Blog
  • To get your best Hepcdac quote visit our online pharmacy.

Generic components: Daclatasvir

Usually prescribed to treat chronic hep c infection

Original Brand Manufactured by Bristol-Myers Squibb

Hepcdac Launch

On 17th December 2105, Mylan Pharma got approval for generic Daclatasvir Dihydrochloride (“ Daclatasvir”) tablets, Hepcdac 30mg & Hepcdac 60mg, from Drugs Controller General (India). Daclatasvir (Hepcdac) is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Compared to other treatment options, this combination not only increases the cure rate but is also regarded as a valuable treatment option in some of the difficult-to-treat HCV patient subsets.

U.S. Food and Drug Administration approved Hepcdac (Daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections on July 24, 2015. Hepcdac (Daclatasvir) is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of interferon or ribavirin, two FDA-approved drugs also used to treat HCV infection.

Write Your Own Review
You're reviewing:Hepcdac Tablet (Daclatasvir)
Your Rating
More Information
Equivalent Brand:Daklinza
Generic Search:Daclatasvir
Strength:60 mg